Two-year outcomes of trabeculo-canalectomy for glaucoma secondary to iridocorneal endothelial syndrome: a retrospective study - Summary - MDSpire

Two-year outcomes of trabeculo-canalectomy for glaucoma secondary to iridocorneal endothelial syndrome: a retrospective study

  • By

  • Zhan Xie

  • Haiyue Xie

  • Yangyang Lu

  • YingTing Zhu

  • Ping Xie

  • Hong Sun

  • July 15, 2026

Share

Objective:

To evaluate the 2-year outcomes of trabeculo-canalectomy in Chinese patients with glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE).

Approach:
  • Study Design: Retrospective study involving 26 GS-ICE patients treated with trabeculo-canalectomy and followed for 2 years, with outcomes assessed at multiple follow-up visits.
  • Surgical Procedure: Trabeculo-canalectomy performed without antimetabolites by the same experienced surgeon, following a standardized protocol.
Key Findings:
  • Postoperative mean IOP significantly reduced from 31.10 ± 11.00 mmHg preoperatively to 13.27 ± 2.68 mmHg at 1 week and remained lower at subsequent follow-ups (p < 0.001).
  • The number of postoperative anti-glaucoma medications decreased significantly, reaching 0 at all follow-up visits (p < 0.001).
  • Complete success rate at 2 years was 80.8% (p < 0.001), while conditional success was 11.5%.
  • Hyphema was the most common early complication (7.7%), self-resolving within the first week.
Interpretation:

Trabeculo-canalectomy demonstrates favorable outcomes in controlling IOP and reducing medication needs in GS-ICE patients over a 2-year period.

Limitations:
  • Retrospective design may introduce selection bias.
  • Small sample size of 26 patients limits generalizability.
Conclusion:

Trabeculo-canalectomy provides effective IOP control and reduces the need for anti-glaucoma medications with a low complication rate in GS-ICE patients over a 2-year period.

Original Source(s)

Related Content